Dibromotyrosine
From Wikipedia, the free encyclopedia
 |
|
|
Dibromotyrosine
|
|
| Systematic (IUPAC) name | |
| (2S)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl) propanoic acid |
|
| Identifiers | |
| CAS number | ? |
| ATC code | H03 |
| PubChem | |
| Chemical data | |
| Formula | C9H9Br2NO3 |
| Mol. mass | 338.981 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dibromotyrosine is an antithyroid preparation.
|
||||||||
 |
This article about an organic halide is a stub. You can help Wikipedia by expanding it. |
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
